The conditions of use of news releases conform to the terms of use governing the investor relations pages.

Archives

2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000

2005

	Oct/18/2005		Taisho Revises Earnings Forecasts for FY2005 First Half and Full Year
	Sep/27/2005		Notice Concerning Establishment of Joint Venture
	Aug/ 3/2005		Approval and Marketing of a Switch OTC Product for the Treatment of Allergic Rhinitis
	Jul/11/2005		Taisho Forges Business and Capital Ties with Yomeishu Seizo
	Jul/ 6/2005		Taisho and Lilly Concluded a License Agreement for Taisho's Potential New Drug for Treatment of Type 2 Diabetes
	Jul/ 5/2005		Launch of "Pabron" and "Taisho Kampo" in Thailand
	May/24/2005		Taisho Announces Cancellation of Treasury Stock
	May/24/2005		Taisho to Conclude Share Buybacks
	Apr/ 7/2005		Collaborative Marketing of Topical Anti-inflammatory Analgesics
	Apr/ 1/2005		Notice of TSE Decision to Delist Stock Certificate Options for Taisho Pharmaceutical Stock
	Mar/22/2005		Taisho Now Provides Information via Cell Phones
	Mar/ 3/2005		Release of "RiUP Lady," a Minoxidil Product
	Mar/ 3/2005		Release of "PreRiUP L" Series, a Total Hair Care Range of Products
	Feb/17/2005		Taisho Has Obtained Approval to Manufacture a Medical Hair Growth Treatment, RiUP for Women
	Feb/ 4/2005		Taisho Announces Cancellation of Treasury Stock

Adobe Reader is required to view these files. Adobe Reader is distributed free of charge by Adobe Systems Incorporated.

Page Top